Evaluation of the Presence of Epstein-Barr virus (EBV) In Iranian Patients with Thyroid Papillary Carcinoma

Publication date: Available online 28 January 2017
Source:Pathology - Research and Practice
Author(s): Maryam Homayouni, Seyed Ali Mohammad Arabzadeh, Fatemeh Nili, Farideh Razi, Mahsa Mohammad Amoli
Background and purpose:Papillary thyroid carcinoma (PTC) is the most common thyroid cancer. EBV is one of the most important viruses related to different types of malignancies. This study investigated the relationship between EBV and papillary thyroid carcinoma.Material and methodsIn this study the presence of Epstein-Barr Nuclear Antigen 1(EBNA1) gene in papillary thyroid carcinoma tissues were examined by nested-PCR method. Paraffin-embedded tissues (N=41) blocks of thyroid cancer were used. DNA was extracted from all samples and then samples were evaluated for the presence of EBV gene.ResultsIn 41 samples, EBNA1 was detected in 65.8% of patients with papillary thyroid carcinoma which was significantly higher in younger ages.ConclusionThe significant presence of EBV genome in papillary thyroid carcinoma suggests that this virus may play a role in this cancer especially in younger ages. As a result, monitoring of patients with EBV latent infection for PTC can be very important.



http://ift.tt/2jEZrN9